EXECUTIVE SUMMARY - GOLD

inflammation and etiology of acute
exacerbations of chronic bronchitis. Chest
2000;118(6):1557-65.
211. White AJ, Gompertz S, Bayley DL, Hill
SL, O’Brien C, Unsal I, et al. Resolution of
bronchial inflammation is related to bacterial
eradication following treatment of
exacerbations of chronic bronchitis. Thorax
2003;58(8):680-5.
212. Murphy TF, Brauer AL, Grant BJ, Sethi
S. Moraxella catarrhalis in Chronic
Obstructive Pulmonary Disease: Burden of
Disease and Immune Response. Am J Respir
Crit Care Med 2005;172(2):195-9.
213. Emerman CL, Connors AF, Lukens TW,
Effron D, May ME. Relationship between
arterial blood gases and spirometry in acute
exacerbations of chronic obstructive
pulmonary disease. Ann Emerg Med
1989;18(5):523-7.
214. Adams S, J. M, Luther M. Antibiotics are
associated with lower relapse rates in
outpatients with acute4 exacerbations of
chronic obstructive pulmonary disease. Chest
2000;117:1345-52.
215. Mueller C, Laule-Kiliam K, Frana B,
Rodriguez D, Rudez J, Swcholer A, et al. The
use of B-natriuretic peptide in the managment
of elderly patients with acute dyspenae. J
Intern Med 2005;258:77-85.
216. Richards AM, Nicholls MG, Epiner EA,
Lainchbury JD, Troughton RW, Elliott J, et al.
B-type natriuretic peptide and ejectrion
fraction for prognosis after myocardial
infarction. Circulation 2003;107:2786.
217. Casas A, Troosters T, Garcia-Aymerich
J., Roca J, Hernandez C, Alonso A, del Pozzo
F, de Toledo P, Anto JM, Rodriguez-Roisin
R, Decramer M: members of the CHRONIC
Project. Integrated care prevents
hospitalisations for exacerbations in COPD
patients. Eur Respir J 2006 Jul:28(1):123-30
218. Ojoo JC, Moon T, McGlone S, Martin K,
Gardiner ED, Greenstone MA, et al. Patients’
and carers’ preferences in two models of care
for acute exacerbations of COPD: results of a
randomised controlled trial. Thorax
2002;57(2):167-9.
219. Skwarska E, Cohen G, Skwarski KM,
Lamb C, Bushell D, Parker S, et al.
Randomised controlled trial of supported
discharge in patients with exacerbations of
chronic obstructive pulmonary disease.
Thorax 2000;55(11):907-12.
220. Hernandez C, Casas A, Escarrabill J,
Alonso J, Puig- Junoy J, Farrero E, et al.
Home hospitalisation of exacerbated chronic
obstructive pulmonary disease patients. Eur
Respir J 2003;21(1):58-67.
221. Thompson WH, Nielson CP, Carvalho P,
Charan NB, Crowley JJ. Controlled trial of
oral prednisone in outpatients with acute
COPD exacerbation. Am J Respir Crit Care
Med 1996;154(2 Pt 1):407-12.
222. Davies L, Angus RM, Calverley PM. Oral
corticosteroids in patients admitted to hospital
with exacerbations of chronic obstructive
pulmonary disease: a prospective randomised
controlled trial. Lancet 1999;354(9177):456-
60.
223. Niewoehner DE, Erbland ML, Deupree
RH, Collins D, Gross NJ, Light RW, et al.
Effect of systemic glucocorticoids on
exacerbations of chronic obstructive